We are live on ! Find out more
BCM

Bayesian Capital Management Portfolio holdings

AUM $156M
1-Year Est. Return 14.89%
This Fund
S&P 500
This Quarter Est. Return
+5.6%
1 Year Est. Return
+14.89%
3 Year Est. Return
+106.87%
5 Year Est. Return
+133.82%
10 Year Est. Return
+1,146.09%
AUM
$383M
AUM Growth
-$51.9M
Cap. Flow
-$65M
Cap. Flow %
-16.98%
Top 10 Hldgs %
21.34%
Holding
731
New
218
Increased
59
Reduced
110
Closed
344

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$9.03M
2
AAPL icon
Apple
AAPL
+$8.95M
3
MRNA icon
Moderna
MRNA
+$7.35M
4
GS icon
Goldman Sachs
GS
+$5.62M
5
XYZ
Block Inc
XYZ
+$5.37M

Sector Composition

Rank Sector Weight
1 Technology 18.71%
2 Consumer Discretionary 18.29%
3 Healthcare 10.57%
4 Consumer Staples 10.44%
5 Industrials 9.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IBB icon
176
iShares Biotechnology ETF
IBB
$10.3B
$556K 0.15%
+3,400
New +$524K
XHB icon
177
State Street SPDR S&P Homebuilders ETF
XHB
$1.29B
$550K 0.14%
+7,508
New +$555K
NVST icon
178
Envista
NVST
$4.01B
$549K 0.14%
12,700
+2,061
+19% +$89.4K
GPN icon
179
Global Payments
GPN
$23.7B
$544K 0.14%
2,903
+303
+12% +$61K
TCOM icon
180
Trip.com Group
TCOM
$24.8B
$543K 0.14%
+15,300
New +$583K
IRM icon
181
Iron Mountain
IRM
$33.4B
$525K 0.14%
12,400
-6,800
-35% -$285K
KL
182
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
$522K 0.14%
13,541
-12,559
-48% -$504K
SOFI icon
183
SoFi Technologies
SOFI
$22.3B
$521K 0.14%
+27,200
New +$504K
HSBC icon
184
HSBC
HSBC
$349B
$518K 0.14%
+17,958
New +$548K
VIPS icon
185
Vipshop
VIPS
$5.78B
$516K 0.13%
+25,700
New +$646K
EXC icon
186
Exelon
EXC
$43.8B
$514K 0.13%
+16,263
New +$524K
WYNN icon
187
Wynn Resorts
WYNN
$9.03B
$514K 0.13%
+4,200
New +$535K
SE icon
188
Sea Limited
SE
$63.5B
$512K 0.13%
1,866
-6,761
-78% -$1.72M
ABCL icon
189
AbCellera Biologics
ABCL
$3.75B
$504K 0.13%
+22,900
New +$631K
HAE icon
190
Haemonetics
HAE
$4.8B
$500K 0.13%
+7,500
New +$531K
COHR icon
191
Coherent
COHR
$53B
$494K 0.13%
+6,811
New +$479K
WOOF icon
192
Petco
WOOF
$682M
$491K 0.13%
+21,900
New +$512K
FTCH
193
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
$486K 0.13%
+9,650
New +$458K
KLIC icon
194
Kulicke & Soffa
KLIC
$4.15B
$477K 0.12%
7,800
+3,233
+71% +$174K
DISCK
195
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$475K 0.12%
16,400
+9,053
+123% +$281K
LNT icon
196
Alliant Energy
LNT
$17.2B
$474K 0.12%
+8,500
New +$482K
DHI icon
197
D.R. Horton
DHI
$39.3B
$470K 0.12%
5,200
-16,341
-76% -$1.53M
INSP icon
198
Inspire Medical Systems
INSP
$2.17B
$469K 0.12%
2,427
-887
-27% -$176K
CROX icon
199
Crocs
CROX
$5.35B
$466K 0.12%
4,000
+206
+5% +$20.3K
MSM icon
200
MSC Industrial Direct
MSM
$6.73B
$465K 0.12%
+5,177
New +$473K

Similar funds

Bayesian Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Bayesian Capital Management held 731 positions worth $383M, down 12% from $435M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Bayesian Capital Management withdrew a net $65M in Q2 2021, closing 344 positions and reducing 110 holdings. Its most notable exit was Microsoft, an estimated $9.03M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 26% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Bayesian Capital Management opened a new position in General Mills worth $11M.

  • Bayesian Capital Management's largest Q2 2021 buy was General Mills: 180,673 shares worth $11M.
  • Bayesian Capital Management added most to Amazon in Q2 2021, an estimated $7.31M increase.
  • Bayesian Capital Management's biggest Q2 2021 reduction was Apple, cutting an estimated $8.95M.
  • Bayesian Capital Management fully exited Microsoft in Q2 2021, selling an estimated $9.03M.
  • Bayesian Capital Management's ten largest holdings make up 21% of its $383M portfolio in Q2 2021.
  • Bayesian Capital Management opened 218 new positions and closed 344 in Q2 2021.
  • Bayesian Capital Management's portfolio value fell 12% quarter-over-quarter to $383M.

Based on Bayesian Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.